To support for National Regulatory Authority for vaccines and medicines; for developing a new Pharmaceutical Strategy; for National Centralized Procurement Centre

Scope of work

WHO’s work in 2020 is to support MOH for implementing the actions laid out in the CAPA and the revised IDP as a short-term objective, as well as to help develop a roadmap for the NRA to transition to an autonomous, unified and intendent agency such as a FDA (Food and Drug Administration) as a long-term objective. In addition, WHO Viet Nam aims to support MOH to expand its scope of regulatory systems strengthening to include medicines and other medical devices for the future.

Since 2014, Vietnam Prime Minister has approved the Decision No. 68/QD-TTg on the National strategy on development of the Vietnam pharmaceutical industry up to 2020, with a vision toward 2030. The strategy with the aims of providing adequate, timely, quality, and reasonably priced medicines according to each disease model corresponding to each stage of socio-economic development; and ensuring safe and rational use of medicines. The strategy also paid attention to providing medicine to social policy beneficiaries, ethnic minorities, the poor, remote and isolated areas. To align with new Pharmacy Law promulgated in 2016 and to keep up with rapid development of local and international pharmaceutical industry, Vietnam DAV as the main agency in collaboration with other ministries and government agencies, to develop a new National strategy on development of the Vietnam pharmaceutical industry strategy up to 2030, with a vision toward 2035.

Address for application

Administrative Officer

World Health Organization

UN Building, 304 Kim Ma Street, Hanoi, Viet Nam

Or by email at:

wpvnmapplicants@who.int

Deadline for submission

Tuesday 10 March 2020